CD33 CAR T Cells(Beijing Boren Hospital)

N/A

Report date: 2022/08/10 20:00:49

Base Information

Drug NameCD33 CAR T Cells(Beijing Boren Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionMyeloid cell surface antigen CD33 inhibitors
TargetsMyeloid cell surface antigen CD33
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Gao Boren Hospital Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Gao Boren Hospital Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteLeukemia
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A